Clinical Readiness of Vital Sign–Based Sepsis Prediction

• by Li Li, Song Lei, Chansokhon Ngan

• October 27, 2026

FDA expands talazoparib use in prostate cancer

The combination with enzalutamide reduced the risk of radiographic progression or death by 52% .

• by Mouj Hijazi

• October 27, 2026

• 3 min

Food Insecurity in Medical Residents and Fellows

• by Julie L. Oyler, Amber Bird

• October 26, 2026

Impact of prolonged co-trimoxazole prophylaxis on colonization with antibiotic resistant bacteria in persons newly diagnosed with HIV-infection: CoTrimResist—a randomized placebo-controlled trial

• by Bjørn Blomberg, Joel Manyahi, Sabrina John Moyo, Marit Tellevik, Said Aboud, Kanika Kuwelker, Helene Heitmann Sandnes, Rolv Terje Lie, Nina Langeland

• October 20, 2026